Dimension Capital targets up to $750M for third life-sciences fund after strong portfolio performance
Dimension Capital, a New York and San Francisco-based investment firm that blends machine learning with life-science ventures, announced it is launching its third fund.
The firm is seeking up to $750 million in commitments for the new vehicle, which will continue to back companies at the intersection of AI and biotech.
The fundraising effort comes after a recent hot streak in the firm’s portfolio, where several backed companies have reported strong progress, boosting investor confidence.
If successful, the capital will expand Dimension’s ability to support emerging technologies that aim to accelerate drug discovery and development.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Dimension seeks up to $750M for third life sciences fund after string of success”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that